Topics

BioNTech Boosting Pipeline, Manufacturing, Global Presence with $325M in Series B Financing

08:00 EDT 9 Jul 2019 | Genetic Engineering News

BioNTech's $325 million Series B financing proceeds will be used not only toward advancing its pipeline of immuno-oncology candidates, but adding to its manufacturing capacity and exploring an expanded global footprint as well.

The post BioNTech Boosting Pipeline, Manufacturing, Global Presence with $325M in Series B Financing appeared first on GEN - Genetic Engineering and Biotechnology News.

Original Article: BioNTech Boosting Pipeline, Manufacturing, Global Presence with $325M in Series B Financing

NEXT ARTICLE

More From BioPortfolio on "BioNTech Boosting Pipeline, Manufacturing, Global Presence with $325M in Series B Financing"

Quick Search

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...